DNA Diagnostic Market Size, Share, And Trends Analysis Report By Product (Instruments, Reagents, Service & Software), By Technology (PCR, In-Situ Hybridization, Sequencing Technology, Microarray, Mass Spectrometry), By Application (Oncology, Infectious Disease, Pre-implantation Diagnostics, Clinical Diagnostic Confirmation, Prenatal Diagnostics, Myogenic Disorder), Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 540 | Number of pages: 197 | Published Date: Dec 2021

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On DNA Diagnostic Market Size, Share, And Trends Analysis Report By Product (Instruments, Reagents, Service & Software), By Technology (PCR, In-Situ Hybridization, Sequencing Technology, Microarray, Mass Spectrometry), By Application (Oncology, Infectious Disease, Pre-implantation Diagnostics, Clinical Diagnostic Confirmation, Prenatal Diagnostics, Myogenic Disorder), Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

DNA Diagnostic Market is valued at USD 23.76  Billion in 2021 and is expected to reach USD 46.89 Billion by 2028 with a CAGR of 10.2% over the forecast period.

Increasing incidences of chronic diseases and the adoption of new technologies are major factors driving the growth of the Global DNA Diagnostics Market.

Market Analysis of DNA Diagnostic Market Report:-

DNA diagnostics is a technology that permits medical professionals to recognize multiple diseases like, cancer, infectious diseases, and myogenic disorders and to decide the correct treatment for a particular disease. The diagnostic system is beneficial for clinical as well as prenatal diagnostics. This concept has become advanced through the human genome projects and resulted in the disclosure of multiple disease-causing agents.  Remarkable technologies which contain polymerase chain reaction (PCR), microarray technique, sequencing technique and mass spectrometry have also evolved the DNA diagnostic market and help for sample preparation, DNA isolation and others. The revolutions in designing the product and improved technologies have induced doctors as well as researchers to switch the focus from traditional methods to personalized diagnostic methods.

Global DNA diagnostic market report is segmented on the basis of product, technology, application, end-user and regional & country level. Based upon the product, the DNA diagnostic market is segmented into instruments, reagents and service & software. Based on technology, the DNA diagnostic market is segmented into PCR, microarray, in-situ hybridization, sequencing technology, and mass spectrometry. Based on application, market is classified into oncology, infectious disease, myogenic disorder, clinical diagnostic confirmation, prenatal diagnostics, pre-implantation diagnostics and others. The end-user segment is categorized into point of care, diagnostic center, and self E testing/OTC.

The regions covered in this DNA diagnostic market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of  DNA diagnostic is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

DNA Diagnostics Companies

Some major key players for the DNA diagnostics market are

  • Sysmex Corporation
  • Bayer Corporation
  • Roche Diagnostics
  • Abbott Laboratories
  • Cepheid Inc.
  • Hologic Corporation
  • Illumina
  • Novartis International Ag
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories 
  • others.

DNA Diagnostic Market is valued at USD 23.76  Billion in 2021

Global DNA Diagnostic Market Segmentation:

By Product:

  • Instruments
  • Reagents
  • Service & Software

By Technology:

  • PCR
  • In-Situ Hybridization
  • Sequencing Technology
  • Microarray
  • Mass Spectrometry
  • others

By Application:

Oncology

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others

Infectious Disease

  • Hepatitis B Virus
  • Hepatitis C Virus
  • HIV
  • TB
  • Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG)
  • HPV
  • Others

Pre-implantation Diagnostics

Clinical Diagnostic Confirmation

Prenatal Diagnostics

Myogenic Disorder

Others

By End-User:

  • Diagnostic Center
  • Point of care
  • Self-Testing/OTC

DNA Diagnostics Market Dynamics–

The increasing pervasiveness of chronic and infectious diseases, growing acceptance of personalized medicines, developing healthcare infrastructure in developing economies, and most importantly raising the geriatric population fuelling the growth of this market. In addition, technological advancements followed by development of strong methodologies like sequence technology, microarray, novel gene sequencing, myogenic disorder and others are also supplementing the market growth. Furthermore, growing priorities for systematic diagnostic staging and increasing research and development activities are some of the other major factors driving the growth of the DNA diagnostic market. However, the development process required high cost for tests followed by reciprocal involvement that gives the inaccurate result and the strict regulating requirements are the issues that may hamper the market growth. Moreover, the undiscovered market in the DNA diagnostics field of the developing economies, new product launches, partnership and collaboration with medical industries and others are forming new trends in the DNA diagnostics market.

Regional Analysis-

The DNA diagnostic market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is anticipated to dominate the global DNA diagnostics market owing to the growing pervasiveness of infectious and chronic diseases and the acceptance of new technologies of the DNA diagnostic testing in this region. According to WHO statistics, most frequently registered sexually transmitted infection is Chlamydia in the US with more than 1.4 million diagnosed with an addition of 1.4 million people that are undiagnosed. The various governments in North America are taking initiatives with increased funding for DNA testing.

Asia-Pacific is anticipated to witness significant growth in this market in upcoming years. The reasons behind the growth of Asia-Pacific region are rise in healthcare expenditure, huge pool of untested or undiagnosed patients in the countries and increasing awareness regarding the advanced healthcare treatments in the countries such as China and India.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2022 - 2028
Market Size in 2021: USD 23.76  Billion
Base year considered 2021
Forecast Period CAGR %:

10.2%

Market Size Expected in 2028: USD 46.89 Billion
Tables, Charts & Figures: 175
Pages 200
DNA Diagnostics Companies Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc., Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc., Bio-Rad Laboratories and others.
Segments Covered By Product, By Technology, By Application
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for DNA Diagnostics Market Report

  • DNA diagnostics Market report covers in-depth historical and forecast analysis.
  • DNA diagnostics Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • DNA diagnostics Market report helps to identify opportunities in the marketplace.
  • DNA diagnostics Market report covers extensive analysis of emerging trends and competitive landscape.

On Demand DNA Diagnostic Market Report is also available for the below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Top Trending Other Reports:

DNA Sequencing Electrophoresis Market Size, Share, Companies & Trends Analysis Report 2021-2027


Frequently Asked Questions (FAQ) :
DNA Diagnostic Market is expected to reach USD 46.89 Billion by 2028 with the CAGR of 10.2% over the forecast period.
DNA Diagnostic Market is valued at USD 23.76 Billion in 2021
North America is anticipated to dominate the global DNA diagnostics market.
Increasing pervasiveness of chronic and infectious diseases, growing acceptance of personalized medicines, developing healthcare infrastructure in developing economies and most importantly raising the geriatric population fuelling the growth of this market.
Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc., Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc., Bio-Rad Laboratories and others.



Interested in this report?

DNA Diagnostic Market Size, Share, Trends, Growth, And Analysis By 2028

report cover

DNA Diagnostic Market Size, Share, And Trends Analysis Report By Product (Instruments, Reagents, Service & Software), By Technology (PCR, In-Situ Hybridization, Sequencing Technology, Microarray, Mass Spectrometry), By Application (Oncology, Infectious Disease, Pre-implantation Diagnostics, Clinical Diagnostic Confirmation, Prenatal Diagnostics, Myogenic Disorder), Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?